Dr. Lehman has served as BioServe’s Chief Technical Officer since 1993. Terri is responsible for development and maintenance of all standard operating procedures (SOPs) for all research work, as well as quality control across all products and services.
Prior to BioServe, Terri worked as a post-doctoral fellow at the National Cancer Institute and National Institutes of Health. At these institutions she helped develop PCR and sequencing techniques to investigate point mutations in the p53 tumor suppressor gene and the ras protooncogene in a variety of human samples. Lehman received her Ph.D. from The Ohio State University in the Department of Physiological Chemistry.